Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Slavin

Showing results (111-120 of 436) with videos related to

Pageof 44
Sort By:
Experimental and Molecular Pathology|February 1, 1983
Successful treatment of autoimmune manifestations in MRL/l and MRL/n mice using total lymphoid irradiation (TLI)M Moscovitch, E Rosenmann, Z Neeman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
A partial characterization of suppressor cells in the spleens of mice conditioned with fractionated total lymphoid irradiation (TLI)R D May, S Slavin, E S Vitetta
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1989
Selective abrogation of alloreactivity via priming in the presence of aphidicolin, a specific inhibitor of DNA polymeraseS Morecki, S Slavin, S A Ben-Sasson
Gene Therapy|May 9, 2000
Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vectorC Hiller, S Wittmann, S Slavin, et al.
Experimental Hematology|December 1, 1995
Inhibition of leukemic cell proliferation by one or more factors released from splenic BCL1 cellsH Bessler, J Hart, S Slavin, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1995
Induction of tumor immunity by intact irradiated leukemic B cells (BCL1) bearing a tumor-associated cell-surface idiotype and the costimulatory B7 moleculeS Morecki, S Levi, Y Puyesky, et al.
Experimental Hematology|July 25, 2000
Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritisS Slavin, A Nagler, G Varadi, et al.
Transplantation Proceedings|December 29, 1998
Deletion of donor-reactive cells followed by stem cell transplantation in recipients treated with total lymphoid-irradiation as a means for induction of transplantation tolerance to organ allografts and xenograftsS Slavin, O Gurevitch, J Zhu, et al.
Bone Marrow Transplantation|July 1, 1990
IL-2 activated cell-mediated immunotherapy: control of minimal residual disease in malignant disorders by allogeneic lymphocytes and IL-2S Slavin, A Ackerstein, E Kedar, et al.
Leukemia Research|October 1, 1992
Effects of interleukin 2 on engraftment following autologous bone marrow transplantation (ABMT) in dogsS Samuel, A Nagler, R Or, et al.
Pageof 44

Showing results (111-120 of 436) with videos related to

Sort By:
Pageof 44
Experimental and Molecular Pathology|February 1, 1983
Successful treatment of autoimmune manifestations in MRL/l and MRL/n mice using total lymphoid irradiation (TLI)M Moscovitch, E Rosenmann, Z Neeman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
A partial characterization of suppressor cells in the spleens of mice conditioned with fractionated total lymphoid irradiation (TLI)R D May, S Slavin, E S Vitetta
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1989
Selective abrogation of alloreactivity via priming in the presence of aphidicolin, a specific inhibitor of DNA polymeraseS Morecki, S Slavin, S A Ben-Sasson
Gene Therapy|May 9, 2000
Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vectorC Hiller, S Wittmann, S Slavin, et al.
Experimental Hematology|December 1, 1995
Inhibition of leukemic cell proliferation by one or more factors released from splenic BCL1 cellsH Bessler, J Hart, S Slavin, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1995
Induction of tumor immunity by intact irradiated leukemic B cells (BCL1) bearing a tumor-associated cell-surface idiotype and the costimulatory B7 moleculeS Morecki, S Levi, Y Puyesky, et al.
Experimental Hematology|July 25, 2000
Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritisS Slavin, A Nagler, G Varadi, et al.
Transplantation Proceedings|December 29, 1998
Deletion of donor-reactive cells followed by stem cell transplantation in recipients treated with total lymphoid-irradiation as a means for induction of transplantation tolerance to organ allografts and xenograftsS Slavin, O Gurevitch, J Zhu, et al.
Bone Marrow Transplantation|July 1, 1990
IL-2 activated cell-mediated immunotherapy: control of minimal residual disease in malignant disorders by allogeneic lymphocytes and IL-2S Slavin, A Ackerstein, E Kedar, et al.
Leukemia Research|October 1, 1992
Effects of interleukin 2 on engraftment following autologous bone marrow transplantation (ABMT) in dogsS Samuel, A Nagler, R Or, et al.
Pageof 44